Biological systems engineering scientist develops critical vaccines for human, pig diseases

Mar 21, 2014 by Amy Loeffler
Biological systems engineering scientist develops critical vaccines for human, pig diseases
Mike Zhang, professor of biological systems engineering, is conducting vaccine research in the new Human and Agricultural Biosciences Building I.

Pig herds infected with porcine reproductive and respiratory syndrome can be financially devastating to farmers. The syndrome causes reproductive failure in sows and respiratory disfunction in young pigs.

Mike Zhang, a professor in the Department of Biological Systems Engineering, which is in both the College of Agriculture and Life Sciences and the College of Engineering, is researching how to develop a vaccine to combat this porcine pandemic that costs farmers as much as $560 million per year. The disease is one of the most economically devastating illnesses to the swine industry.

Current vaccines exist that are not as effective as using modified live viruses to stimulate an immune response from the pig, and using any iteration of live viruses would be too risky to use on industrial-sized food-animal populations.

"The challenge is to develop safe and effective vaccines," said Zhang.

Zhang is working to develop a recombinant universal vaccine that has similar strains to the live virus, but carries no threat of the animal contracting the disease. His research is now being conducted in the newly constructed 93,860-square-foot Human and Agricultural Biosciences Building 1. The increased lab space and state-of-the-art facilities will be good for productivity, he said.

He also works on developing vaccines for humans to breath easier as well, but in a vastly different endeavor that seeks to eliminate addiction to nicotine in tobacco products.

Zhang uses a nanocarrier system that can effectively present the nicotine haptens to the immune system. Haptens are small molecules that elicit an when attached to a larger carrier such as a protein.

He is also using the same nanotechnology to fight cancer by using nanoparticles to deliver treatment to specifically targeted cells and tissues.

Zhang is funded in part by grants from the United States Department of Agriculture and the Institute for Critical Technology and Applied Science.

"All of my research is very different," said Zhang. "But it all has the potential to benefit society."

Explore further: New research into Post Weaning Multisystemic Wasting Syndrome

add to favorites email to friend print save as pdf

Related Stories

Research team collaborate to save the bacon

Jul 23, 2013

A research team from the University of Missouri and Kansas State University has been working to find a cure for a specific virus that affects pigs and costs the hog industry $800 million annually. In their latest study, the ...

Taking aim at deadly swine diseases

Dec 18, 2013

U.S. Department of Agriculture (USDA) scientists are stepping up their efforts to help fight deadly swine viruses that are prevalent in other countries and pose a threat to the United States.

Using nanocapsules to deliver vaccines to lungs

Sep 25, 2013

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines ...

Fighting foot-in-mouth disease

Dec 06, 2013

Proteins called interferons are among the latest weapons U.S. Department of Agriculture (USDA) scientists are using to combat foot-and-mouth disease (FMD). These proteins kill or stop viruses from growing ...

Recommended for you

Quest to unravel mysteries of our gene network

8 hours ago

There are roughly 27,000 genes in the human body, all but a relative few of them connected through an intricate and complex network that plays a dominant role in shaping our physiological structure and functions.

EU court clears stem cell patenting

10 hours ago

A human egg used to produce stem cells but unable to develop into a viable embryo can be patented, the European Court of Justice ruled on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.